Your browser doesn't support javascript.
loading
RECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1.
Abu-Libdeh, Bassam; Jhujh, Satpal S; Dhar, Srijita; Sommers, Joshua A; Datta, Arindam; Longo, Gabriel Mc; Grange, Laura J; Reynolds, John J; Cooke, Sophie L; McNee, Gavin S; Hollingworth, Robert; Woodward, Beth L; Ganesh, Anil N; Smerdon, Stephen J; Nicolae, Claudia M; Durlacher-Betzer, Karina; Molho-Pessach, Vered; Abu-Libdeh, Abdulsalam; Meiner, Vardiella; Moldovan, George-Lucian; Roukos, Vassilis; Harel, Tamar; Brosh, Robert M; Stewart, Grant S.
Affiliation
  • Abu-Libdeh B; Department of Pediatrics and Genetics, Makassed Hospital and Al-Quds Medical School, East Jerusalem, Palestine.
  • Jhujh SS; Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Dhar S; Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, Maryland, USA.
  • Sommers JA; Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, Maryland, USA.
  • Datta A; Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, Maryland, USA.
  • Longo GM; Institute of Molecular Biology (IMB), Mainz, Germany.
  • Grange LJ; Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Reynolds JJ; Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Cooke SL; Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • McNee GS; Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Hollingworth R; Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Woodward BL; Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Ganesh AN; Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Smerdon SJ; Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Nicolae CM; Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
  • Durlacher-Betzer K; Department of Genetics and.
  • Molho-Pessach V; Paediatric Dermatology Service, Department of Dermatology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Abu-Libdeh A; Department of Pediatrics and Genetics, Makassed Hospital and Al-Quds Medical School, East Jerusalem, Palestine.
  • Meiner V; Department of Genetics and.
  • Moldovan GL; Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
  • Roukos V; Institute of Molecular Biology (IMB), Mainz, Germany.
  • Harel T; Department of Genetics and.
  • Brosh RM; Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, Maryland, USA.
  • Stewart GS; Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
J Clin Invest ; 132(5)2022 03 01.
Article in En | MEDLINE | ID: mdl-35025765
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: J Clin Invest Year: 2022 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: J Clin Invest Year: 2022 Document type: Article Country of publication: Estados Unidos